About Orbuculum
Orbuculum is a Healthcare company based in India by Pranav Gangwal and Faiz Ahmad. AI-based solutions for disease prediction are provided using genomic data. Its chief executive, as recorded, is Pranav Gangwal. Its Indian entity Orbuculum Genolytics Private Limited reported revenue of βΉ1.3 Lakh. Its focus areas include Life Sciences, Genomics, Genome Informatics and Integrative Bioinformatics Platforms.
Company details
AI-based solutions for disease prediction are offered by Orbuculum, a company located in India. Genomic data is analyzed to forecast risks for conditions such as cancer, diabetes, neurological disorders, and cardiovascular diseases. The company was co-founded by Pranav Gangwal, serving as CEO, and Faiz Ahmad. Operations center on applying artificial intelligence within the healthcare and genomics sectors to aid in early detection.
- Headquarters India
- Founders Pranav Gangwal, Faiz Ahmad
- SectorsHealthcare
- Website orbuculum.in
- Legal Name Orbuculum Genolytics Private Limited
- Date of Incorporation 25 Aug, 2017
- Jurisdiction Indore, Madhya Pradesh, India
- Annual Revenue₹1.3 Lakh
FY 2024 · -82% YoY
- Net Loss-₹5.5 Lakh
FY 2024 · -437% margin
- EBITDA-₹5.5 Lakh
FY 2024 · -437% margin
- Investors
Associated legal entities of Orbuculum
Orbuculum operates through Orbuculum Genolytics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Orbuculum Genolytics Private Limited CIN U72900MP2017PTC044014 | Active | 25 Aug 2017 | Indore, Madhya Pradesh | ₹0.0 Cr | 34 | 2 | View details |
Funding Insights of Orbuculum
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Orbuculum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2017 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in Orbuculum
Orbuculum has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Axilor Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech startups are supported via VC-backed acceleration programs. | axilor.com/accelerator | Bengaluru, India |
Investor details for Orbuculum
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Orbuculum Genolytics Private Limited (Orbuculum)
Orbuculum Genolytics Private Limited is the primary company behind Orbuculum. The board of Orbuculum Genolytics Private Limited currently have 2 directors; the longest-serving is Pranav Gangwal, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pranav Gangwal DIN 07902045 | Director | 25 Aug 2017 | 9 yrs 2 mo | Orbuculum Genolytics Private Limited |
| Prafull Kumar Gangwal DIN 02119335 | Director | 25 Mar 2023 | 3 yrs 7 mo | Orbuculum Genolytics Private Limited |
People of Orbuculum
2 people are tracked at Orbuculum (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
Faiz Ahmad | Co-Founder | Leadership |
Complete people profiles for Orbuculum
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Orbuculum
Figures of Orbuculum Genolytics Private Limited, the primary company behind Orbuculum, for FY 2024. Revenue was ₹1.3 Lakh (-82% year on year). Net loss was -₹5.5 Lakh (-437% margin). EBITDA was -₹5.5 Lakh (-437% margin). Revenue has grown at a compounded annual rate of +6% over three years.
- ₹1.3 LakhRevenue · FY 2024 · -82% YoY
- -₹5.5 LakhNet loss · -437% margin
- -₹5.5 LakhEBITDA · -437% margin
- ₹1.7 LakhPaid-up capital
- 34Employees (provident fund records)
- +6%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Orbuculum Genolytics Private Limited are on its company page.
Detailed financial statements for Orbuculum
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orbuculum
Orbuculum is headquartered in India.
Pranav Gangwal is the CEO of Orbuculum, as recorded in our data. They have also founded this company.
The primary company behind Orbuculum, Orbuculum Genolytics Private Limited, reported revenue of βΉ1.3 Lakh for FY 2024, down 82% year on year.
AI-based solutions for disease prediction are offered by Orbuculum, a company located in India. Genomic data is analyzed to forecast risks for conditions such as cancer, diabetes, neurological disorders, and cardiovascular diseases. The company was co-founded by Pranav Gangwal, serving as CEO, and Faiz Ahmad. Operations center on applying artificial intelligence within the healthcare and genomics sectors to aid in early detection.
Orbuculum has 1 investor. Key investors include Axilor Accelerator.
Orbuculum operates through Orbuculum Genolytics Private Limited.
The legal entities of Orbuculum currently have 2 directors, including Pranav Gangwal, Prafull Kumar Gangwal.
